195 related articles for article (PubMed ID: 29475967)
1. An Examination of HPV16 Natural Immunity in Men Who Have Sex with Men (MSM) in the HPV in Men (HIM) Study.
Beachler DC; Pinto LA; Kemp TJ; Nyitray AG; Hildesheim A; Viscidi R; Schussler J; Kreimer AR; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):496-502. PubMed ID: 29475967
[No Abstract] [Full Text] [Related]
2. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections.
Safaeian M; Porras C; Schiffman M; Rodriguez AC; Wacholder S; Gonzalez P; Quint W; van Doorn LJ; Sherman ME; Xhenseval V; Herrero R; Hildesheim A;
J Natl Cancer Inst; 2010 Nov; 102(21):1653-62. PubMed ID: 20944077
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
Singini MG; Muchengeti M; Sitas F; Chen WC; Combes JD; Waterboer T; Clifford GM
Int J Cancer; 2024 Jul; 155(2):251-260. PubMed ID: 38577820
[TBL] [Abstract][Full Text] [Related]
4. Anal HPV 16 and 18 viral load: A comparison between HIV-negative and -positive MSM and association with persistence.
Marra E; King A; van Logchem E; van der Weele P; Mooij SH; Heijman T; Meijer CJLM; Verhagen DWM; van der Sande MAB; Schim van der Loeff MF
J Med Virol; 2018 Jan; 90(1):76-83. PubMed ID: 28700080
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of healthy volunteers with human papillomavirus type 16 L2E7E6 fusion protein induces serum antibody that neutralizes across papillomavirus species.
Gambhira R; Gravitt PE; Bossis I; Stern PL; Viscidi RP; Roden RB
Cancer Res; 2006 Dec; 66(23):11120-4. PubMed ID: 17145854
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus 16 and 18 L1 serology compared across anogenital cancer sites.
Carter JJ; Madeleine MM; Shera K; Schwartz SM; Cushing-Haugen KL; Wipf GC; Porter P; Daling JR; McDougall JK; Galloway DA
Cancer Res; 2001 Mar; 61(5):1934-40. PubMed ID: 11280749
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus 16 L1 gene methylation as a potential biomarker for predicting anal intraepithelial neoplasia in men who have sex with men (MSM).
Chaiwongkot A; Phanuphak N; Pankam T; Bhattarakosol P
PLoS One; 2021; 16(9):e0256852. PubMed ID: 34469465
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.
Kreimer AR; Brennan P; Lang Kuhs KA; Waterboer T; Clifford G; Franceschi S; Michel A; Willhauck-Fleckenstein M; Riboli E; Castellsagué X; Hildesheim A; Fortner RT; Kaaks R; Palli D; Ljuslinder I; Panico S; Clavel-Chapelon F; Boutron-Ruault MC; Mesrine S; Trichopoulou A; Lagiou P; Trichopoulos D; Peeters PH; Cross AJ; Bueno-de-Mesquita HB; Vineis P; Larrañaga N; Pala V; Sánchez MJ; Navarro C; Barricarte A; Tumino R; Khaw KT; Wareham N; Boeing H; Steffen A; Travis RC; Quirós JR; Weiderpass E; Pawlita M; Johansson M
J Clin Oncol; 2015 Mar; 33(8):877-84. PubMed ID: 25667279
[TBL] [Abstract][Full Text] [Related]
9. HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in London.
King EM; Mesher D; Sonnenberg P; Linley E; Panwar K; Beddows S; Soldan K; Borrow R; Jit M; Gilson R
Sex Transm Infect; 2021 Aug; 97(5):382-386. PubMed ID: 33361466
[TBL] [Abstract][Full Text] [Related]
10. Prevalent serum antibody is not a marker of immune protection against acquisition of oncogenic HPV16 in men.
Lu B; Viscidi RP; Wu Y; Lee JH; Nyitray AG; Villa LL; Lazcano-Ponce E; da Silva RJ; Baggio ML; Quiterio M; Salmeron J; Smith DC; Abrahamsen ME; Papenfuss MR; Stockwell HG; Giuliano AR
Cancer Res; 2012 Feb; 72(3):676-85. PubMed ID: 22123925
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of the Quadrivalent HPV Vaccine in Preventing Anal ≥ HSILs in a Spanish Population of HIV+ MSM Aged > 26 Years.
Hidalgo-Tenorio C; Pasquau J; Omar-Mohamed M; Sampedro A; López-Ruz MA; López Hidalgo J; Ramírez-Taboada J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498165
[TBL] [Abstract][Full Text] [Related]
13. Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach.
Bogaards JA; Mooij SH; Xiridou M; Schim van der Loeff MF
PLoS Med; 2019 Mar; 16(3):e1002756. PubMed ID: 30830901
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
[TBL] [Abstract][Full Text] [Related]
15. Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infection.
Vriend HJ; Bogaards JA; van der Klis FR; Scherpenisse M; Boot HJ; King AJ; van der Sande MA;
PLoS One; 2013; 8(4):e60696. PubMed ID: 23637760
[TBL] [Abstract][Full Text] [Related]
16. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
Trevisan A; Candeias JMG; Thomann P; Villa LL; Franco EL; Trottier H; The Ludwig-McGill Study Group
J Med Microbiol; 2020 Jul; 69(7):960-970. PubMed ID: 32510304
[No Abstract] [Full Text] [Related]
17. Effect of naturally acquired type-specific serum antibodies against human papillomavirus type 16 infection.
Triglav T; Artemchuk H; Oštrbenk A; Elfström KM; Faust H; Poljak M; Dillner J
J Clin Virol; 2017 May; 90():64-69. PubMed ID: 28363164
[TBL] [Abstract][Full Text] [Related]
18. Seroepidemiology of Human Papillomavirus 16 (HPV16) L2 and Generation of L2-Specific Human Chimeric Monoclonal Antibodies.
Wang JW; Jagu S; Wu WH; Viscidi RP; Macgregor-Das A; Fogel JM; Kwak K; Daayana S; Kitchener H; Stern PL; Gravitt PE; Trimble CL; Roden RB
Clin Vaccine Immunol; 2015 Jul; 22(7):806-16. PubMed ID: 25972404
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence.
Lang Kuhs KA; Kreimer AR; Trivedi S; Holzinger D; Pawlita M; Pfeiffer RM; Gibson SP; Schmitt NC; Hildesheim A; Waterboer T; Ferris RL
Cancer; 2017 Nov; 123(22):4382-4390. PubMed ID: 28950407
[TBL] [Abstract][Full Text] [Related]
20. Association of antibody to E2 protein of human papillomavirus and p16
Chuerduangphui J; Pientong C; Swangphon P; Luanratanakorn S; Sangkomkamhang U; Tungsiriwattana T; Kleebkaow P; Burassakarn A; Ekalaksananan T
Med Oncol; 2018 May; 35(6):93. PubMed ID: 29744680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]